Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Publication | Closed Access

DOI

187

Citations

References

1997

Year

R. David Anderson, E. Magnus Ohman, David R. Holmes, Jacques Col, Amanda Stebbins, Eric R. Bates, Robert J. Stomel, Christopher B. Granger, Eric J. Topol, Robert M. Califf

Journal of the American College of Cardiology

Cardiogenic ShockCardiovascular DiseasePharmacotherapyIntraaortic Balloon CounterpulsationNew YorkMedicineCardiologyEmergency MedicineAcute Myocardial InfarctionMyocardial Infarction